d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] A prospective phase II study to evaluate alternations in molecular biomarkers in HER2-positive metastatic breast cancer together with assessment of trastuzumab use beyond progression efter initial exposure to trastuzumab-taxane based treatment [Country] SE [Cancer type] 
Breast cancer
Nordic NECT - Inclusion completed
Cancer type